CHELMSFORD, Mass. — ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it is the first company to achieve premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to continue to market and distribute its full line of defibrillators in the U.S. The list of defibrillators that received PMA approval include the R Series® ...
from EMS via xlomafota13 on Inoreader http://ift.tt/2EAo4Cd
via IFTTT
Παρασκευή 12 Ιανουαρίου 2018
ZOLL first company to receive premarket approval from the FDA on its full portfolio of defibrillators
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.